Central oxytocinergic neurotransmission: A drug target for the therapy of psychogenic erectile dysfunction

Current Drug Targets

Volumn 4, Issue 1, 2003, Pages 55-66

  Melis, M R ^a   Argiolas, A ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID RECEPTOR STIMULATING AGENT; AMYL NITRITE; APOMORPHINE; BROMOCRIPTINE; DIZOCILPINE; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; EXCITATORY AMINO ACID; GLYCERYL TRINITRATE; HALOPERIDOL; HEXARELIN; LEVODOPA; LISURIDE; LY 71555; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; OPIATE; OPIATE PEPTIDE; OXYTOCIN; OXYTOCIN RECEPTOR; PEPTIDE DERIVATIVE; SULPIRIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CELL ACTIVATION; COPULATION; DRUG TARGETING; ELECTROSTIMULATION; ENZYME ACTIVATION; ERECTILE DYSFUNCTION; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS PERIVENTRICULAR NUCLEUS; MALE; MEDULLA OBLONGATA; NEUROTRANSMISSION; NONHUMAN; PENIS ERECTION; PSYCHOGENIC IMPOTENCE; REVIEW; SEXUAL BEHAVIOR; SPINAL CORD;

ANIMALS; DOPAMINE AGONISTS; EXCITATORY AMINO ACID AGONISTS; GABA AGONISTS; GROWTH SUBSTANCES; HUMANS; IMPOTENCE; MALE; NARCOTICS; NEURONS; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; OXYTOCIN; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS;

EID: 0037238721     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389450033347190     Document Type: Review

References (123)

1. Meisel, R.L. and Sachs, B.D. (1994) In The Physiology of Reproduction, (Knobil, E. and Neil, J. Eds.), Raven Press, New York, Vol. 2; pp. 3-96.
2. Sachs, B.D. and Meisel, R.L. (1988) In The Physiology of Reproduction, (Knobil, E. and Neil, J. Eds.), Raven Press, New York, Vol. 2, pp 1393-1485.
3. Andersson, J.E. and Wagner, G. (1995) Physiol. Rev., 75, 191-236.
4. Argiolas, A. and Melis, R.M. (1995) Progr. Neurobiol., 47, 235-255.
5. Garcia-Reboll, L.; Mulhall, J.P. and Goldstein, I. (1997) Drug and Aging, 11, 140-151.
6. Moreland, R.B.; Hsieh, G.; Nakame, M. and Brioni, J.D. (2001) J. Pharmacol. Exp. Ther., 296, 225-234.
7. Hull, E.M.; Bitran, D.; Pehek, E.A.; Warner, R.K.; Band, L.C. and Holmes, G.M. (1986) Brain Res., 370, 73-81.
8. Hull, E.M.; Warner, R.K.; Bazzett, T.J.; Eaton, R.C. and Thompson, J.T. (1989) J. Pharmacol. Exp. Ther., 251, 422-427.
9. Hull, E.M.; Du, J.; Lorrain, D.S. and Matuszewich, L. (1995) J. Neurosci., 15, 7465-7471.
10. Sato, Y.; Wada, H.; Horita, H.; Suzuki, N.; Shibuya, A.; Adachi, H.; Kato, R.; Tsukamoto, T. and Kumamoto, Y. (1995) Brain Res., 692, 66-74.
11. Sato, Y.; Zhao, W. and Christ, G.J. (2001) Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, R269-278
12. Sato, Y. and Christ, G.J. (2000) Am. J. Physiol. Heart Circ. Physiol., 278, H964-970.
13. Giuliano, F.; Rampin, O.; Brown, K.; Courtois, F.; Benoit, G. and Jardin, A. (1996) Neurosci. Lett., 209, 1-4.
14. Liu, Y.C.; Salamone, J.D. and Sachs, B.D. (1997) J. Neurosci., 17, 5245-5253.
15. Matuszewich, L.; Lorrain, D.S. and Hull, E.M. (2000) Behav. Neurosci., 114, 772-782.
16. Melis, M.R.; Argiolas, A. and Gessa, G.L. (1986) Brain Res., 398, 259-265.
17. Melis, M.R.; Argiolas, A. and Gessa, G.L. (1987) Brain Res., 415, 98-104.
18. Melis, M.R.; Succu, S.; Mauri, A. and Argiolas, A. (1998) Eur. J. Neurosci., 10, 1968-1974.
19. Melis, M.R.; Succu, S.; Spano, M.S. and Argiolas, A. (1999) Eur. J. Neurosci., 11, 1857-1864.
20. Melis, M.R. and Argiolas, A. (2002) Eur. J. Neurosci, 15, 852-860.
21. Eaton, R.G.; Markowski, V.F.; Lumley, L.A.; Thompson, J.T.; Moses, J. and Hull, E.M. (1992) Pharmacol. Biochem. Behav., 39, 177-181.
22. Dominguez, J.; Riolo, J.V.; Xu, Z. and Hull, M.E. (2001) J. Neurosci., 21, 349-355.
23. Marson, L. and McKenna, K.E. (1990) Brain Res., 515, 303-308.
24. Marson, L. and McKenna, K.E. (1992) Exp. Brain Res., 88, 313-318.
25. Marson, L. and McKenna, K.E. (1994) Brain Res., 638, 103-108.
26. Marson, L.; List, M.S. and McKenna, K.E. (1992) Brain Res., 592, 187-192.
27. Marson, L.; Platt, K.B. and McKenna, K.E. (1993) Neuroscience, 55, 263-280.
28. Marson, L. and McKenna, K.E. (1996) J. Comp. Neurol., 374, 161-179.
29. Rampin, O.; Bernabè, J. and Giuliano, F. (1997) World J. Urol., 15, 2-13.
30. Tang., Y.; Rampin, O.; Calas, A.; Facchinetti, P. and Giuliano, F. (1998) Neuroscience, 82, 241-254.
31. Bancila, M.; Verge, D.; Rampin, O.; Backstrom, J.R.; Sanders-Bush, E.; McKenna, K.E.; Marson, L.; Calas, A. and Giuliano, F. (1999) Neuroscience, 92, 1523-1537.
32. Veronneau-Longueville, F.; Rampin, O.; Freund-Mercier, M.J.; Tang, Y.; Calas, A.; Marson, L.; McKenna, K.E.;. Stoeckel, M.E.; Benoit, G. and Giuliano, F. (1999) Neuroscience, 93, 1437-1447.
33. Giuliano, F.; Allard, J.; Rampin, O.; Droupy, S.; Benoit, G.; Alexandre, L. and Bernabè, J. (2001) Int. J. Impot. Res., 13, 110-115.
34. Giuliano, F.; Bernabè, J.; McKenna, K.E.; Longueville, F. and Rampin, O. (2001) Am. J. Physiol. Regul. Integr. Comp. Physiol., 280, R1870-1877.
35. Giuliano, F.; Allard, J.; Rampin, O.; Droupy, S.; Benoit, G.; Alexandre, L. and Bernabè, J. (2002) J. Urol., 167, 402-406.
36. Giuliano, F. and Allard, J. (2001) Int. J. Impot. Res., 13 (Suppl.3), 18-28.
37. Du Vigneaud, V.; Ressler, C.; Swan, J.; Roberts, C.W; Katsovannis, P.G. and Gordon, S. (1953) J. Am. Chem. Soc., 75, 4879-4883.
38. Amico, J.A. and Robinson, A.G. (1985) Oxytocin, Clinical and Laboratory Studies, Excerpta medica, Amsterdam-New York-Oxford.
39. Ivell, R. and Russel, J.A. (1995) Oxytocin: Cellular and Molecular Approaches in Medicine and Research, Plenum Press, New York.
40. Buijs, R.M. (1978) Cell Tissue Res., 192, 423-435.
41. Sofroniew, M.W. (1983) Trends Neurosci., 6, 467-472.
42. Argiolas, A. and Gessa, G.L. (1991) Neurosci. Biobehav. Rev., 15, 217-231.
43. Carter, C.S.; Lederhendler, I.I. and Kirkpatrick, B. (1997) The Interactive Neurobiology of Affiliation, Annals of the New York Academy of Sciences, Vol. 807.
44. Pedersen, C.A.; Caldwell, J.D.; Jirikowski, G.F. and Insel, T.R. (1992) Oxytocin in Maternal, Sexual, and Social Behaviors, Annals of the New York Academy of Sciences, Vol. 652.
45. Argiolas, A.; Melis, M.R. and Gessa, G.L. (1985) Eur. J. Pharmacol., 117, 395-396.
46. Argiolas, A. (1999) Neurosci. Biobehav. Rev., 23, 1127-1142.
47. Chen, K.K.; Chan, S.H.H.; Chang, L.S. and Chan, J.Y.H. (1997). J. Urol., 158, 238-244.
48. Giuliano, F. and Rampin, O. (2000) Neurosci. Biobehav. Rev., 24, 517-533.
49. McKenna, K.E. (1998) Int. J. Impotence Res., 10 (Suppl. 1), 25-34.
50. McKenna, K.E. (2000) Neurosci. Biobehav. Rev., 24, 535-540.
51. Wagner, C.K. and Clemens, L.G. (1993) J. Comput. Neurol., 336, 106-116.
52. Melis, M.R. and Argiolas, A. (1995) Neurosci. Biobehav. Rev., 19, 19-38.
53. Melis, M.R.; Spano, M.S.; Succu, S.; Locatelli, V.; Torsello, A.; Muller, E.E.; Deghenghi, R. and Argiolas, A. (2000) Int. J. Impotence Res., 12, 255-262.
54. Melis, M.R.; Succu, S.; Spano, M.S.; Locatelli, V.; Torsello, A.; Muller, E.E.; Deghenghi, R. and Argiolas, A. (2000) Eur. J. Pharmacol., 401, 137-143.
55. Melis, M.R.; Succu, S.; Spano, M.S.; Torsello, A.; Locatelli, V.; Muller, E.E.; Deghenghi, R. and Argiolas, A. (2001) Eur. J. Pharmacol., 411, 305-310.
56. Deghenghi, R. (1996) In Growth Hormone Secretagogues, (Bercu, B.B. and Walker, R.F. Eds.), Springer, New York, pp 85-102.
57. Deghenghi, R.; Cananzi, M.M.; Torsello, A.; Battisti, C; Muller, E.E. and Locatelli, V. (1994) Life Sci., 54, 1321-1328.
58. Muller, E.E.; Locatelli, V. and Cocchi, D. (1999) Physiol. Rev., 79, 511-607.
59. Melis, M.R.; Succu, S.; Spano, M.S.; Deghenghi, R. and Argiolas, A. (2001) Neuropharmacology, 41, 254-262.
60. Dahlstrom, A. and Fuxe, K. (1964) Acta Physiol. Scand., 62 (Suppl. 232), 1-54.
61. Buijs, R.M.; Geffard, M.; Pool, C.W. and Hoorneman, E.M.D. (1984) Brain Res., 323, 65-72.
62. Lindvall, O.; Bjorklund, A. and Skagerberg, G. (1984) Brain Res., 306, 19-30.
63. Cameron, J.L.; Pomerantz, S.M.; Layden, L.M. and Amico, J.A. (1992) J. Clin. Endocrinol. Metab., 75, 855-860.
64. Melis, M.R.; Argiolas, A. and Gessa, G.L. (1989) Neurosci. Lett., 98, 351-355.
65. Melis, M.R.; Argiolas, A.; Stancampiano, R. and Gessa, G.L. (1990) Eur. J. Pharmacol., 182, 101-107.
66. Argiolas, A.; Melis, M.R. and Stancampiano, R. (1993) Reg. Pept., 45, 139-142
67. Argiolas, A.; Melis, M.R.; Mauri, A. and Gessa, G.L. (1987) Brain Res., 421, 349-352.
68. Hawthorn, J.; Ang, V.T. and Jenkins, J.S. (1985) Brain Res., 346, 51-57.
69. Melis, M.R.; Argiolas, A. and Gessa, G.L. (1989) Eur. J. Phamaol., 164, 565-570.
70. Argiolas, A.; Collu, M.; Gessa, G.L.; Melis, M.R. and Serra, G. (1988) Eur. J. Pharmacol., 149, 389-392.
71. McCleskey, E.W.; Fox, A.P.; Feldman, D.H.; Cruz, L.J.; Olivera, B.M.; Tsien, R.W. and Yoshikami, D. (1987) Proc. Natl. Acad. Sci. U.S.A., 84, 4327-4331.
72. Argiolas, A.; Melis, M.R.; Stancampiano, R. and Gessa, G.L. (1990) Pharmacol. Biochem. Behav., 37, 253-257.
73. Melis, M.R.; Stancampiano, R. and Argiolas, A. (1994) Pharmacol. Biochem. Behav., 48, 799-804.
74. Melis, M.R.; Succu, S. and Argiolas, A. (1996) Eur. J. Neurosci., 8, 2056-2063.
75. Melis, M.R.; Spano, M.S.; Succu, S. and Argiolas, A. (2000) Behav. Neurosci., 114, 849-857.
76. Melis, M.R.; Stancampiano, R. and Argiolas, A. (1994) Pharmacol. Biochem. Behav., 48, 203-207.
77. Roeling, T.A.P.; Van Erp, A.M.M.; Meelis, W.; Kruk, M.R. and Veening, J.G. (1991) Brain Res., 550, 220-224.
78. Wong, E.H.F.; Knight, A.R. and Woodruff, G.N. (1988) J. Neurochem., 50, 274-281.
79. Van Den Pol, A. (1991) J. Neurosci., 11, 2087-2101.
80. Bankowski, K.; Manning, M.; Seto, J.; Halder, J. and Sawyer, W.H. (1980) Int. J. Pept. Prot. Res., 16, 382-391.
81. Melis, M.R.; Succu, S.; Iannucci, U. and Argiolas, A. (1997) Eur. J. Pharmacol., 328, 115-123.
82. Snyder, S. H. (1992) Science, 254, 494-496.
83. Chen, K.-K.; Chan, J.Y.H.; Chang, L.S.; Chen, M.-T. and Chan, S.H.H. (1992) Neurosci. Lett., 141, 218-222.
84. Saphier, D. and Feldman, S. (1987) Neuroscience, 20, 749-755.
85. Melis, M.R.; Spano, M.S.; Succu, S. and Argiolas, A. (1999) Neurosci. Lett., 265, 171-174.
86. Bredt, D.S. and Snyder, S.H. (1990) Proc. Natl. Acad. Sci. U.S.A., 87, 682-685.
87. Sanchez, F.; Alonso, J.R.; Arevalo, R.; Blanco, E.; Aijon, J. and Vazquez, R. (1994) Cell Tissue Res., 276, 31-34.
88. Sato-Suzuki, I.; Kita, I.; Oguri, M. and Arita, H. (1998) J. Neurophysiol., 80, 2765-2775.
89. Vincent, S.R. and Kimura, H. (1992) Neuroscience, 46, 755-784.
90. Argiolas, A. (1994) Neuropharmacology, 33, 1339-1344
91. Melis, M.R. and Argiolas, A. (1995) Eur. J. Pharmacol., 294, 1-9.
92. Melis, M.R.; Stancampiano, R.; Lai, C. and Argiolas, A. (1995) Brain Res. Bull., 36, 527-531.
93. Sato, Y.; Christ, G.J.; Horita, H.; Adachi, H.; Suzuki, N.; Tsukamoto, T. (1999) J. Urol., 162, 2182-2185.
94. Southam, E. and Garthwaite, J. (1993) Neuropharmacology, 32, 1267-1277.
95. Melis, M.R. and Argiolas, A. (1997) Prog. Neuro-Psychopharmacol. & Biol. Psychiat., 21, 899-922.
96. Torres, G.; Soon, L. and Rivier, C. (1993) Mol. Cell. Neurosci., 4, 155-163.
97. Melis, M.R. and Argiolas, A. (1993) Brain Res. Bull., 32, 71-74.
98. Melis, M.R.; Succu, S.; Iannucci, U. and Argiolas, A. (1997) Reg. Peptides, 69, 105-112.
99. Benelli, A.; Bertolini, A.; Poggioli, R.; Cavazzutti, E.; Calzà, L.; Giardino, L. and Arletti, R. (1955) Eur. J. Pharmacol., 294, 505-112.
100. Argiolas, A.; Melis, M.R. and Gessa, G.L. (1986) Eur. J. Pharmacol., 130, 265-272.
101. Arletti, R.M. and Bertolini, A. (1985) Neuropeptides, 6, 247-255.
102. Arletti, R.; Bazzani, C.; Castelli, M. and Bertolini, A. (1985) Horm. Behav., 19, 14-20.
103. Caldwell, J.D.; Prange, A.J. and Pedersen, C.A. (1986) Neuropeptides, 7, 175-189.
104. Gorzalka, B.B. and Lester, G.L. (1987) Neuropeptides, 10, 55-65.
105. Melis, M.R.; Argiolas, A.; Stancampiano, R. and Gessa, G.L. (1989) Peptides, 10, 559-563.
106. Argiolas, A.; Melis, M.R.; Vargiu, G.L. and Gessa, G.L. (1987) Eur. J. Pharmacol., 134, 221-224.
107. Succu, S.; Spano, M.S.; Melis, M.R. and Argiolas, A. (1998) Eur. J. Pharmacol., 359, 19-26.
108. Arletti, A.; Calzà, L.; Giardino, L.; Benelli, A.; Cavazzutti, E. and Bertolini, A. (1997) Neurosci. Lett., 233, 65-68.
109. Melis, M.R.; Spano, M.S.; Succu, S. and Argiolas, A. (2000) Neurosci. Lett., 281, 127-130.
110. Kojima, M.; Hosoda, H.; Date, Y.; Nakazato, M.; Matsuo, H. and Kangawa, K. (1999) Nature, 402, 656-660.
111. Hosoda, H.; Kojima, M.; Matsuo, H. and Kangawa, K. (2000) J. Biol. Chem., 275, 21995-22000.
112. Pfaus, J.G. and Gorzalka, B.B. (1987) Neurosci. Biobehav. Rev., 11, 1-34.
113. Pfaus, J.G. and Everitt, B.J. (1995) In Psychopharmacology: the Fourth Generation of Progress, (Knobil, F.E. and Kupfer, D.J. Eds.), Raven Press, New York, pp 742-758.
114. Cushman, P. (1972) NY State J. Med., 72, 1261-1266.
115. Melis, M.R.; Stancampiano, R; Gessa, G.L. and Argiolas, A. (1992) Neuropsychopharmacology, 6, 17-21.
116. Melis, M.R.; Succu, S. and Argiolas, A. (1997) Brain Res. Bull., 44, 689-694.
117. Melis, M.R.; Succu, S.; Iannucci, U. and Argiolas, A. (1997) Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 595-600.
118. Muhlethaler, M.; Gahwiler, B.H. and Deifruss, J.J. (1980) Brain Res., 197, 264-268.
119. Hobbs, W.R.; Rail, T.W.; Verdoon, T.A. (1996) In Goodmans and Gilman's The Pharmacological Basis of Therapeutics; (Molinoff, P.B. and Ruddon, R.W. Eds.), The McGraw-Hill Companies Inc., New York, pp. 361-396.
120. Melis, M.R.; Succu, S.; Maxia, M.S. and Argiolas, A. (2001) Neurosci. Lett., 314, 123-126.
121. Boubada, C.; Szabò, K. and Tasker, G. (1996) J. Neurosci., 15, 7151-7160.
122. Roland, B.L. and Sawchenko, P.E. (1983) J. Comp. Neurol., 332, 123-143.
123. Wise, R.A. and Rompre, P.-P. (1989) Annu. Rev. Psychol., 40, 191-225.